Envista Holdings Corporation (NYSE:NVST – Get Free Report) SVP Mischa Reis sold 8,000 shares of the firm’s stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $27.50, for a total value of $220,000.00. Following the sale, the senior vice president directly owned 27,321 shares in the company, valued at $751,327.50. The trade was a 22.65% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Envista Stock Up 1.1%
NYSE:NVST opened at $27.76 on Thursday. Envista Holdings Corporation has a 1 year low of $18.77 and a 1 year high of $30.42. The company has a current ratio of 2.43, a quick ratio of 2.07 and a debt-to-equity ratio of 0.47. The stock has a market cap of $4.46 billion, a price-to-earnings ratio of 47.86, a PEG ratio of 1.31 and a beta of 0.86. The stock has a 50-day moving average price of $27.06 and a two-hundred day moving average price of $26.38.
Envista (NYSE:NVST – Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.41 EPS for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07. Envista had a return on equity of 7.88% and a net margin of 3.33%.The company had revenue of $730.50 million for the quarter, compared to analyst estimates of $716.11 million. During the same quarter last year, the firm posted $0.26 earnings per share. Envista’s revenue was up 7.1% compared to the same quarter last year. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. As a group, equities analysts expect that Envista Holdings Corporation will post 1.53 earnings per share for the current year.
Hedge Funds Weigh In On Envista
Wall Street Analyst Weigh In
A number of brokerages have weighed in on NVST. Evercore reaffirmed an “outperform” rating and issued a $33.00 price target on shares of Envista in a research note on Thursday, May 7th. Morgan Stanley set a $23.00 price objective on shares of Envista in a report on Thursday, August 6th. Mizuho set a $29.00 price objective on shares of Envista in a research report on Thursday, August 6th. BMO Capital Markets assumed coverage on shares of Envista in a research note on Wednesday, July 8th. They issued a “market perform” rating and a $27.00 target price for the company. Finally, Barclays lowered their target price on Envista from $34.00 to $32.00 and set an “overweight” rating for the company in a report on Thursday, June 11th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and nine have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $29.31.
Check Out Our Latest Stock Analysis on NVST
About Envista
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
Recommended Stories
- Five stocks we like better than Envista
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
